Pregabalin: its pharmacology and use in pain management - PubMed (original) (raw)

Review

Pregabalin: its pharmacology and use in pain management

Noor M Gajraj. Anesth Analg. 2007 Dec.

Erratum in

• Anesth Analg.2008 May;106(5):1584

Abstract

Pregabalin is a new synthetic molecule and a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid. It is an alpha2-delta (alpha2-delta) ligand that has analgesic, anticonvulsant, anxiolytic, and sleep-modulating activities. Pregabalin binds potently to the alpha2-delta subunit of calcium channels, resulting in a reduction in the release of several neurotransmitters, including glutamate, noradrenaline, serotonin, dopamine, and substance P. In this review, I will discuss the pharmacology of pregabalin and available efficacy studies in pain management. This review will focus on the advances in pregabalin pharmacology since my previous review in 2005.

PubMed Disclaimer

Similar articles

• Pregabalin for pain management.
  Gajraj NM. Gajraj NM. Pain Pract. 2005 Jun;5(2):95-102. doi: 10.1111/j.1533-2500.2005.05205.x. Pain Pract. 2005. PMID: 17177755
• Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
  Taylor CP, Angelotti T, Fauman E. Taylor CP, et al. Epilepsy Res. 2007 Feb;73(2):137-50. doi: 10.1016/j.eplepsyres.2006.09.008. Epub 2006 Nov 28. Epilepsy Res. 2007. PMID: 17126531 Review.
• Pregabalin: From molecule to medicine.
  Kavoussi R. Kavoussi R. Eur Neuropsychopharmacol. 2006 Jul;16 Suppl 2:S128-33. doi: 10.1016/j.euroneuro.2006.04.005. Epub 2006 Jun 9. Eur Neuropsychopharmacol. 2006. PMID: 16765030 Review.
• Efficacy and tolerability of pregabalin in partial epilepsy.
  Beydoun A, Nasreddine W, Atweh S. Beydoun A, et al. Expert Rev Neurother. 2008 Jul;8(7):1013-24. doi: 10.1586/14737175.8.7.1013. Expert Rev Neurother. 2008. PMID: 18590472 Review.
• The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?
  Stahl SM, Porreca F, Taylor CP, Cheung R, Thorpe AJ, Clair A. Stahl SM, et al. Trends Pharmacol Sci. 2013 Jun;34(6):332-9. doi: 10.1016/j.tips.2013.04.001. Epub 2013 May 2. Trends Pharmacol Sci. 2013. PMID: 23642658 Review.

Cited by

• The analgesic efficiency of pregabalin for the treatment of postoperative pain in total hip arthroplasty: A randomized controlled study protocol.
  Zhang Y, Wang X, Dong G. Zhang Y, et al. Medicine (Baltimore). 2020 Jul 2;99(27):e21071. doi: 10.1097/MD.0000000000021071. Medicine (Baltimore). 2020. PMID: 32629738 Free PMC article. Clinical Trial.
• Does pregabalin have neuropsychotropic effects?: a short perspective.
  Marks DM, Patkar AA, Masand PS, Pae CU. Marks DM, et al. Psychiatry Investig. 2009 Jun;6(2):55-8. doi: 10.4306/pi.2009.6.2.55. Epub 2009 Jun 30. Psychiatry Investig. 2009. PMID: 20046375 Free PMC article.
• Pregabalin-induced urticarial rash and neutropenia in a renal transplant recipient: a case report.
  Sahota S, Parry RG, Gentile G. Sahota S, et al. BMC Nephrol. 2019 Jun 6;20(1):207. doi: 10.1186/s12882-019-1401-3. BMC Nephrol. 2019. PMID: 31170935 Free PMC article.
• Postoperative respiratory depression with pregabalin: a case series and a preoperative decision algorithm.
  Eipe N, Penning J. Eipe N, et al. Pain Res Manag. 2011 Sep-Oct;16(5):353-6. doi: 10.1155/2011/561604. Pain Res Manag. 2011. PMID: 22059207 Free PMC article.
• Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study.
  Alkhalaf AA, Bukhari RA, Alshehri EA, Alshehri SO, Badr AF. Alkhalaf AA, et al. J Taibah Univ Med Sci. 2021 Jun 3;16(5):700-705. doi: 10.1016/j.jtumed.2021.04.009. eCollection 2021 Oct. J Taibah Univ Med Sci. 2021. PMID: 34690650 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Other Literature Sources

  • H1 Connect

• Medical

  • MedlinePlus Health Information